Immediate Parent -Infant Skin-to-Skin Study (IPISTOSS)

December 16, 2021 updated by: Björn Westrup, MD PhD

The World Health Organization recommend all stable low birth weight neonates to have Skin-to-skin-Contact (SSC) after birth. Intermittent SSC is used in Sweden in neonatal units. Observations indicate that SSC makes neonates feel good. However, there is limited research done on SSC treatment on neonates born prior to week 33.

The aim of this study is to investigate whether Skin-to-skin-Contact (SSC) leads to an improved physiological stabilization, altered epigenetic profile and improved longterm psychomotor outcome in neonates born in gestation age between week 28+0 - 32+6. This is a parallel, two-arm, multicentre, randomized controlled superiority trial. The two arms to be compared are a) immediate SSC with one parent/caregiver continous during the first 6 hours after birth and as much as possible during the first 72 hours, and b) conventional method of care during the same time.

Study Overview

Status

Terminated

Conditions

Study Type

Interventional

Enrollment (Actual)

91

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Stavanger, Norway
        • Stavanger University Hospital
      • Stockholm, Sweden, SE 171 77
        • Department of Women´s and Children´s Health, Karolinska University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Born in gestation week plus days 28+0 - 32+6.
  • Born at maternity ward at study center
  • Consent from parents/caregivers
  • Parent or caregiver or substitute are available to start skin-to-skin Contact during the first hour of life.

Exclusion Criteria:

  • Born outside the hospital
  • Triplets or more
  • Known malformation which will require immediate surgical action
  • On-going resuscitation or intensive Medical care (mechanic ventilation or inotropy) after the first lifespan

    * Known congenital infection

  • Parent/care giver can not communicate in Swedish/Norwegian or English
  • Not suited for the study for other reasons (according to the principal investigator)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Skin-to-skin Contact group
Neonates in gestational age between 28+0 - 32+6 will get continuous Skin-to-skin contact with one parent/caregiver the first 6 hours after birth and as much as possible the first 72 hours after birth.
Neonates will get Skin-to-skin Contact with parent/caregiver continuously the first 6 hours after birth and as much as possible the first 72 hours after birth.
ACTIVE_COMPARATOR: Conventional care group
Neonates in gestational age between 28+0 - 32+6 will get Conventional care - incubators, warmers etc - the first 72 hours after birth.
Neonates will get Conventional care the first 72 hours after birth

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cardiorespiratory stability
Time Frame: After six hours
Using the Stability of the CardioRespiratory system In the Preterm-score (SCRIP-score). A higher SCRIP score indicates greater physiological stability
After six hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Need for respiratory support
Time Frame: After 3 months
Days in respirator from birth to discharge from hospital
After 3 months
Need for surfactant
Time Frame: After 3 months
Number of doses of surfactants from birth to discharge from hospital,
After 3 months
Need of Continuous positive airway pressure
Time Frame: After 3 months
Days in use of Continuous positive airway pressure (CPAP)- from birth to discharge from hospital
After 3 months
Need for oxygen
Time Frame: After 3 months
Days in use of oxygen from birth to discharge from hospital
After 3 months
Heart Rate Variability
Time Frame: Up to 3-4 months
Up to 3-4 months
Body temperature
Time Frame: At 0 hour (postpartum), 1, 2, 3, 4, 5 and 6 hours
Axillary body temperature
At 0 hour (postpartum), 1, 2, 3, 4, 5 and 6 hours
Sepsis episodes
Time Frame: After 3 months
Number of Sepsis episodes from birth to discharge from hospital, based on the Medical records
After 3 months
Number of Antibiotic treatment
Time Frame: After 3 months
Number of Days with antibiotic treatment from birth to discharge from hospital based on Medical records
After 3 months
Status of Breast-feeding
Time Frame: Up to12 months
Status of Breast-feeding according to a specific questionnaire: Index of Breastfeeding (IBS)
Up to12 months
Status of Breast-feeding
Time Frame: Up to12 months
Status of Breast-feeding according to a specific questionnaire: Breastfeeding Self efficacy Questionnaire (BSES)
Up to12 months
Status of Breast-feeding
Time Frame: Up to12 months
Status of Breast-feeding according to a specific questionnaire: Infant Breastfeeding Assessment Tool (IBFAT).
Up to12 months
Time to Full enteral nutrition
Time Frame: After 3 months
Days from birth until Full enteral nutrition
After 3 months
Time in use of Nasogastric tube feeding
Time Frame: After 3 months
Days from birth in use of Nasogastric tube feeding
After 3 months
Time to recovered birth weight
Time Frame: After 3 months
Days from birth until recovered birth weight
After 3 months
Weight gain
Time Frame: Up to 12 months
Weight gain from birth
Up to 12 months
Epigenetic profiling in buccal cells
Time Frame: Up to 24 months
Whole-genome methylation analysis and locus specific analysis of selected stress related genes, will be conducted to investigate early, intermediate and long-term epigenetic changes due to the intervention.
Up to 24 months
Telomere profiling in buccal cells
Time Frame: Up to 24 months
Whole-genome methylation analysis and locus specific analysis of selected stress related genes, will be conducted to investigate telomere length.
Up to 24 months
Epigenetic profiling in blood samples
Time Frame: Up to 24 months
Whole-genome methylation analysis and locus specific analysis of selected stress related genes, will be conducted to investigate early, intermediate and long-term epigenetic changes due to the intervention.
Up to 24 months
Telomere profiling in blood samples
Time Frame: Up to 24 months
Whole-genome methylation analysis and locus specific analysis of selected stress related genes, will be conducted to investigate telomere length
Up to 24 months
Microbiota
Time Frame: 0-6 hours, 72 hours, 3-4 months, 12 and 24 months. Mother is tested at 0-6 hours and partner with skin swabs at 0-6 hours.
The child's colonization with bacteria is identified by DNA-analysis from stool samples, nasal and skin swabs, compared with parents (mother is tested by vaginal, rectal, nasal and skin swabs.
0-6 hours, 72 hours, 3-4 months, 12 and 24 months. Mother is tested at 0-6 hours and partner with skin swabs at 0-6 hours.
Maturation of EEG-pattern
Time Frame: Postnatal day 4-10 and postmenstrual age of 40-42 weeks
Postnatal day 4-10 and postmenstrual age of 40-42 weeks
Structural and functional maturation of the infant brain
Time Frame: At term age
Magnetic Resonance Imaging scans will be performed with a 3 Tesla machine. Three-dimensional and diffusion sequences as well as functional MRI (fMRI) sequences will be performed in order to examine structural and functional maturation respectively. Structural sequences are used to study the different tissues of the brain; diffusion images give information about the connections of the brain (white matter) and fMRI gives information on how the brain integrates information to perform a specific function.
At term age
Maternal brain responsiveness
Time Frame: At 4 months
The maternal brain responses will be evaluated by using structural and functional magnetic resonance imaging to measure structural changes on social, emotional and behavioural networks as well as the cerebral response of mothers viewing neutral, happy and distress face images of their own infant, along with a matched unknown infant. We will use a 3 Tesla machine. We will study cortical and subcortical networks related with the emotional, social and behavioral responses involving the mother-child interactions and responses, such as the insula, the cingulate cortex, the precentral gyrus, the right orbital gyrus, the inferior, middle and superior frontal gyrus the fusiform gyrus, supramarginal gyrus, the superior parietal gyrus, the inferior temporal gyrus, and basal ganglia among others.
At 4 months
Bonding and interaction between parent and child
Time Frame: At 3-4 months and at 12 and 24 months.
A videotaped mother-infant interaction session will be assessed through with the Parent-Child Early Relational Assessment (PCERA)
At 3-4 months and at 12 and 24 months.
Bonding and interaction between parent and child
Time Frame: At 3-4 months
A videotaped mother-infant interaction session will be assessed through the "Still Face situation"
At 3-4 months
Parents' experiences
Time Frame: Up to 12 months
Parents will fill in the following questionnaire: State-Trait Anxiety Index(STAI)
Up to 12 months
Parents' experiences
Time Frame: Up to 12 months
Parents will fill in the following questionnaire: Swedish Parenting Questionnaire (SPSQ)
Up to 12 months
Parents' experiences
Time Frame: Up to 12 months
Parents will fill in the following questionnaire: Edinburgh postnatal Depression Scale (EPDS)
Up to 12 months
Maternal-Child physiological attunement in stress regulation
Time Frame: In the morning and in the evening at the day of discharge, At the day of discharge before and after diaper change, at 3-4 months, at the same day as Still Face-test before and after, at 12 months.
Saliva Cortisol both mother and child
In the morning and in the evening at the day of discharge, At the day of discharge before and after diaper change, at 3-4 months, at the same day as Still Face-test before and after, at 12 months.
Neuro Behaviour of Child
Time Frame: At term age, at 3-4, 12 and 24 months
According to records and to questionnaires for example Infant Behavior Questionnaire (IBQ)
At term age, at 3-4, 12 and 24 months
Neuro Behaviour of Child
Time Frame: At term age, at 3-4, 12 and 24 months
According to records and to questionnaires for example Bayley Scales
At term age, at 3-4, 12 and 24 months
Neuro Behaviour of Child
Time Frame: At term age, at 3-4, 12 and 24 months
According to records and to questionnaires for example Ages and Stages Questionnaire (ASQ)
At term age, at 3-4, 12 and 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Björn Westrup, MD,PhD, Department of Women´s and Children´s Health, Karolinska Institutet, Stockholm, Sweden
  • Principal Investigator: Siren Rettedal, MD, PhD, Stavanger University hospital, Stavanger, Norway
  • Principal Investigator: Wibke Jonas, Ass prof, Department of Women´s and Children´s Health, Karolinska Institutet, Stockholm, Sweden

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 1, 2018

Primary Completion (ACTUAL)

October 12, 2021

Study Completion (ACTUAL)

October 12, 2021

Study Registration Dates

First Submitted

February 20, 2018

First Submitted That Met QC Criteria

May 9, 2018

First Posted (ACTUAL)

May 11, 2018

Study Record Updates

Last Update Posted (ACTUAL)

January 6, 2022

Last Update Submitted That Met QC Criteria

December 16, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe